Table 5.
Relapse-Free Survival | Cancer-Specific Survival | Overall Survival | |||||||
---|---|---|---|---|---|---|---|---|---|
HR | 95% CI | p-value | HR | 95% CI | p-value | HR | 95% CI | p-value | |
PIV (Reference: low) | |||||||||
High | 1.89 | 1.12, 3.19 | 0.017 | 1.07 | 0.57, 2.02 | 0.819 | 1.64 | 1.05, 2.56 | 0.029 |
Age | 0.77 | 0.40, 1.46 | 0.427 | 1.27 | 0.53, 3.04 | 0.579 | 1.11 | 0.61, 2.02 | 0.717 |
Smoking status (Reference: no) | |||||||||
Smoke | 0.91 | 0.53, 1.55 | 0.744 | 1.30 | 0.62, 2.73 | 0.478 | 1.25 | 0.74, 2.10 | 0.401 |
Sex (Reference: male) | |||||||||
Female | 0.86 | 0.49, 1.52 | 0.624 | 1.47 | 0.78, 2.80 | 0.230 | 1.06 | 0.64, 1.75 | 0.811 |
Clinical tumor condition | |||||||||
(Reference: cTa/cTis/cT1) | |||||||||
cT2 | 1.58 | 0.82, 3.05 | 0.168 | 1.03 | 0.42, 2.53 | 0.938 | 1.25 | 0.69, 2.27 | 0.450 |
cT3/cT4 | 7.14 | 3.90, 13.06 | <0.001 | 8.77 | 4.13, 18.61 | <0.001 | 4.02 | 2.24, 7.19 | <0.001 |
Harrel’s index | |||||||||
Model accuracy | 0.72 | 0.72 | 0.66 | ||||||
Model accuracy without PIV | 0.68 (+4%) | 0.71 (+1%) | 0.63 (+3%) | ||||||
(p = difference model) | 0.01 | 0.81 | 0.03 |
PIV = Pan-immune inflammation value; HR = Hazard ratio; CI = Confidence interval.